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The opioid epidemic has ravaged Appalachia. West
Virginia is a state of hard-working individuals, many
with blue collar jobs. As people sought relief from
the pain they were facing performing their normal
daily activities, they turned to opioid medications
for relief. An underestimation of the addictive
potential of these medicines turned this relief into
a catastrophic reality. Gender, race, socioeconomic
status and religion offer no protection from the farreaching grasp of addiction. Age also offers no limits
to the effects of opioids, with newborns affected by
substances they are exposed to while developing in
womb.
The brain of a fetus does not discriminate between
a prescribed opiate (methadone or buprenorphine)
and an illicit one (such as heroin or fentanyl).
Exposure results in specific brain adaptations while
inside the mother. When the baby is born, the infant
is no longer exposed to medications and in essence
“quits cold turkey”. This results in a flood of adrenaline
sweeping through the body. Neonatal withdrawal is
the inappropriate reaction of the baby’s body systems
to its own adrenaline release. Symptoms can include
irritation of the nervous system (crying, tremors,
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sneezing), irritation of the gastrointestinal tract
(vomiting, diarrhea), and fever.
The approach to caring for drug-exposed infants has
changed over time to keep up with both the different
substances babies are exposed to an ever-changing
evidence-based medicine practices.
It typically takes weeks to treat babies exposed to
opiates. Problems multiply when babies are exposed
to many different medications and classes of drugs,
whether they are prescribed or obtained by other
means. Withdrawal becomes more complex in these
cases and after dealing with a very acute phase of
withdrawal, babies may also have to deal with a sub
acute phase that can last for months after discharge.
These babies are at risk for neurodevelopmental
consequences, behavioural and/or cognitive
impairment. It is imperative to identify these children
in order to enable them to receive early intervention
programs if necessary and allow for early recognition
of developing problems as the child grows older.
National research has shown that opioid exposure
increased six times between 2000 and 2009. The
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number of babies affected with neonatal abstinence
syndrome (NAS) followed this trend and tripled over
that time period. The CDC has ranked West Virginia
as number one in the country in terms of neonatal
abstinence syndrome, with 33.4 per 1000 live
births.1 This 3.34% compares to less than 1 percent
nationwide. The CDC numbers do not tell the full
story. West Virginia recognizes the limitations of using
administrative data and through state collaborative
projects has been proactive in identifying affected
infants2,3. More accurate statistics show that 5.2%
of all babies born in the state are diagnosed with
neonatal abstinence syndrome.
For every baby diagnosed with NAS there is a mother
at one of the many stages in the cycle of recovery. It is
important to remember the mother-baby dyad when
discussing neonatal abstinence syndrome. There is so
much potential for the mother to help the baby and
for the baby to help the mother during treatment and
recovery.
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Preparing for the days, weeks, months and years
ahead is necessary for any comprehensive program.
There are no guarantees when it comes to the health
and well-being of men, women and children affected
by substance use disorders, but through education
and support the potential for positive outcomes
grows.
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